Lensar (LNSR) EBT Margin Growth (3y) (2022 - 2026)
Lensar (LNSR) EBT Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 423.00 |
| 10 | Lensar | 101.45 Mn | 87.89 Mn | 9.78 Mn | 3,681.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,801.00 |
| Mar 31, 2026 | 11,528.00 |
| Dec 31, 2025 | -2,402.00 |
| Sep 30, 2025 | -2,884.00 |
| Jun 30, 2025 | -136.00 |
| Mar 31, 2025 | -3,816.00 |
| Dec 31, 2024 | 750.00 |
| Sep 30, 2024 | 13,831.00 |
| Jun 30, 2024 | 8,346.00 |
| Mar 31, 2024 | -232,819.00 |
| Dec 31, 2023 | 9,554.00 |
| Sep 30, 2023 | 771.00 |
| Jun 30, 2023 | 5,907.00 |
| Mar 31, 2023 | -5,290.00 |
| Dec 31, 2022 | -1,756.00 |
| Sep 30, 2022 | -6,026.00 |